Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus Surgical” or “Asensus”), a global leader of innovative digital solutions for the operating room, announces that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc. (“KARL STORZ”), a wholly owned direct subsidiary of KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company. Under the Merger Agreement, KARL STORZ will acquire all of the outstanding shares of Asensus Surgical for $0.35 per share in cash (the “Merger”). The purchase price represents a premium of approximately 67% based on the per share closing price of the Asensus common stock on the NYSE American on April 2, 2024 (the date prior to announcement of a potential transaction).
Read the full article: Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ //
Source: https://www.globenewswire.com/news-release/2024/06/07/2895367/0/en/Asensus-Surgical-Announces-Signing-of-Definitive-Merger-Agreement-with-KARL-STORZ.html